OMIM ID:
Retinitis Pigmentosa 38
Alternate Names
Defective Genes
Clinical Characteristics
Ocular Features
This is a rare clinically heterogeneous condition in which both rods and cones functions are variably affected. It is a progressive disorder with children often being aware of night vision difficulties during the latter half of the first decade of life. Reduced vision is often present at this time as well and progressively deteriorates. Visual fields are constricted to 20-30 degrees. Rod responses may be nondetectable in the first decade.
Central vision is subnormal as early as childhood and progressively worsens with age. Dyschromatopsia to some degree is often present early as well and some patients have a maculopathy with a bull’s eye pattern and thinning of the photoreceptor layer seen on OCT. Attenuated retinal vessels, pale optic discs, and variable fundus pigmentary changes (including pigmentary mottling and bone spicules) have been seen. The degree and course of the photoreceptor damage is variable leading some to propose that RP38 is primarily a cone-rod dystrophy.
Systemic Features
None
Genetics
Inheritance
This is an autosomal recessive disorder resulting from homozygous mutations in the MERTK gene (2q13).
Pedigree
Autosomal recessive
In order for autosomal recessive disorders to be expressed, offspring generally must inherit two mutations, one from each carrier parent. Carriers with only one mutation, such as the parents, do not have clinical disease. Note that carrier parents can expect that 1 in 4 children (25%) will inherit both mutations and have the disorder, 2 in 4 children (50%) will be carriers like their parents, while 1 in 4 children (25%) inherit neither mutation.
In order for autosomal recessive disorders to be expressed, offspring generally must inherit two mutations, one from each carrier parent. Carriers with only one mutation, such as the parents, do not have clinical disease. Note that carrier parents can expect that 1 in 4 children (25%) will inherit both mutations and have the disorder, 2 in 4 children (50%) will be carriers like their parents, while 1 in 4 children (25%) inherit neither mutation.